A unique study of 98 patients, 5 different diagnostic types, including chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy, traumatic neuropathy, and other mixed neuropathies.
http://www.medscape.com/viewarticle/832576
In a pilot group of 10 patients, biopsies performed 2 to 4 months after CET showed that 7 of the 10 patients had regrown their nerves by an average of 81%.